225 results on '"Morici, Lisa A"'
Search Results
2. Establishment of isotype-switched, antigen-specific B cells in multiple mucosal tissues using non-mucosal immunization
3. Mycobacterium bovis bacille Calmette–Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy
4. Vaccine Development Against Melioidosis
5. The Remarkable Innate Resistance of Burkholderia bacteria to Cationic Antimicrobial Peptides: Insights into the Mechanism of AMP Resistance
6. Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria
7. Inhibition of Streptococcus mutans biofilms with bacterial-derived outer membrane vesicles
8. Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
9. Burkholderia thailandensis outer membrane vesicles exert antimicrobial activity against drug-resistant and competitor microbial species
10. 2167. Mutational Signature Analysis to Predict Drug-resistant Pseudomonas aeruginosa
11. 2769. Treatment of Hypermutator Pseudomonas aeruginosa Induces Multidrug Resistance but Can Be Targeted by Combination Therapy
12. Cell Free Bacteriophage Synthesis from Engineered Strains Improves Yield
13. Non-mucosal vaccination strategies to enhance mucosal immunity
14. Hypervirulent Mutant of Mycobacterium tuberculosis Resulting from Disruption of the mce1 Operon
15. Media ion composition controls regulatory and virulence response of Salmonella in spaceflight.
16. Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria
17. A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy
18. Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine
19. Optimization of host cell-compatible, antimicrobial peptides effective against biofilms and clinical isolates of drug-resistant bacteria
20. Evaluation of a Burkholderia Pseudomallei Outer Membrane Vesicle Vaccine in Nonhuman Primates
21. Two-Component Regulatory Systems
22. The role of the Pseudomonas aeruginosa hypermutator phenotype on the shift from acute to chronic virulence during respiratory infection
23. The use of outer membrane vesicles as novel, mucosal adjuvants against intracellular bactiera
24. Vaccination to Prevent Pseudomonas aeruginosa Bloodstream Infections
25. Mycobacterium bovis bacille Calmette–Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy
26. SARS-CoV-2 Epitopes following Infection and Vaccination Overlap Known Neutralizing Antibody Sites
27. Additional file 1 of Inhibition of Streptococcus mutans biofilms with bacterial-derived outer membrane vesicles
28. Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion
29. An Outer Membrane Vesicle-Adjuvanted Oral Vaccine Protects Against Lethal, Oral Salmonella Infection
30. Pseudomonas aeruginosa AlgR represses the Rhl quorum-sensing system in a biofilm-specific manner
31. Synthetic Molecular Evolution to Identify Hemocompatible Antimicrobial Peptides Effective Against Drug-Resistant, Biofilm-Forming Bacteria
32. Bacterial-Derived Outer Membrane Vesicles are Potent Adjuvants that Drive Humoral and Cellular Immune Responses
33. Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine
34. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa
35. Temporary alteration of local social structure in a threatened population of Cuban iguanas (Cyclura nubila)
36. Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce 1 operon
37. EARLY DIVERGENT HOST RESPONSES IN SHIVSF162P3 AND SIVMAC251 INFECTED MACAQUES CORRELATE WITH CONTROL OF VIREMIA: Abstract #74
38. Salmonella Persistence and Host Immunity Are Dictated by the Anatomical Microenvironment
39. An outer membrane vesicle-adjuvanted oral vaccine protects against lethal, oral Salmonella infection
40. Discovering Novel Hemocompatible Antimicrobial Peptides using High-throughput Screening and Rational Variation
41. In situ Treatment With Novel Microbiocide Inhibits Methicillin Resistant Staphylococcus aureus in a Murine Wound Infection Model
42. TRAIL-R as a Negative Regulator of Innate Immune Cell Responses
43. Referee report. For: VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy [version 1; referees: 2 approved]
44. Immunological considerations in the development of Pseudomonas aeruginosa vaccines
45. Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia
46. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis
47. Immunological considerations in the development of Pseudomonas aeruginosa vaccines.
48. 168. Intradermal Immunization Drives Humoral and Cellular Immunity to the Lung and Protects Against Acute P. aeruginosa Pneumonia
49. A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates
50. Consensus on the development of vaccines against naturally acquired melioidosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.